Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Natural Alternat. | 17 | 1 | 0 | 0 | €5.80 | - | - |
| Insmed Inc. | 17 | 0 | 5 | 0 | €23.40 | €44.97 | 92.185% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.00 | €84.74 | 123.011% |
| Novo Nordisk A/S ADR | 17 | 1 | 0 | 0 | €122.50 | €135.22 | 10.383% |
| Abbott Laboratories | 16 | 0 | 2 | 0 | €96.21 | €116.81 | 21.409% |
| Stoke Therapeutics Inc | 15 | 1 | 2 | 0 | €11.80 | €21.00 | 77.997% |
| G1 Therapeutics | 15 | 1 | 2 | 0 | €4.29 | €10.56 | 145.901% |
| Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | €37.20 | €45.98 | 23.602% |
| Bayer AG | 15 | 1 | 1 | 0 | €29.20 | €50.00 | 71.233% |
| Akero Therapeutics Inc | 14 | 0 | 2 | 0 | €19.44 | €38.19 | 96.469% |
| Esperion Therapeutis.Inc. | 14 | 0 | 2 | 0 | €2.00 | €8.39 | 318.473% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €41.33 | €50.33 | 21.782% |
| PTC Therapeutics Inc. | 13 | 5 | 1 | 0 | €28.40 | €41.81 | 47.232% |
| Intellia Therapeutics Inc | 13 | 1 | 1 | 1 | €24.24 | €60.55 | 149.810% |
| Teva Pharmaceutical Industries Ltd ADR | 13 | 1 | 2 | 1 | €15.75 | €18.51 | 17.511% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €160.40 | €184.76 | 15.187% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €62.20 | €86.77 | 39.503% |
| Alkermes plc | 12 | 2 | 0 | 0 | €22.40 | €34.08 | 52.146% |
| Incyte Corp. | 12 | 2 | 3 | 0 | €52.50 | €78.42 | 49.376% |
| MacroGenics Inc. | 12 | 1 | 4 | 1 | €4.05 | €12.42 | 206.934% |
| Geron Corp. | 12 | 0 | 2 | 0 | €3.44 | €4.63 | 34.510% |
| Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €25.79 | €35.43 | 37.376% |
| Chromadex Corp | 11 | 1 | 1 | 0 | €3.16 | €5.58 | 76.449% |
| Celldex Therapeutics | 11 | 1 | 2 | 0 | €36.80 | €56.62 | 53.851% |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €15.58 | €24.13 | 54.948% |